tiprankstipranks
Advertisement
Advertisement

RNXT Stock Latest News

RenovoRx files to sell 8.44M shares of common stock for holders
The FlyRenovoRx files to sell 8.44M shares of common stock for holders
15d ago
RNXT
RenovoRx: Building Commercial Momentum Ahead of TIGeR-PaC Readout Supports Buy-Rated Risk‑Reward Profile
PremiumRatings
RenovoRx: Building Commercial Momentum Ahead of TIGeR-PaC Readout Supports Buy-Rated Risk‑Reward Profile
23d ago
RNXT
RenovoRx secures Japanese patent allowance for targeted drug-delivery
PremiumThe Fly
RenovoRx secures Japanese patent allowance for targeted drug-delivery
23d ago
RNXT
RenovoRx Reports 2025 Results and Advances TIGeR-PaC Trial
PremiumCompany Announcements
RenovoRx Reports 2025 Results and Advances TIGeR-PaC Trial
1M ago
8K
RNXT
RNXT Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
RNXT Upcoming Earnings Report: What to Expect?
1M ago
RNXT
RenovoRx’s TIGeR-PaC Phase III trial surpasses 100 randomized patients
PremiumThe FlyRenovoRx’s TIGeR-PaC Phase III trial surpasses 100 randomized patients
1M ago
RNXT
RenovoRx Raises $10 Million in Oversubscribed Private Placement
Premium
Company Announcements
RenovoRx Raises $10 Million in Oversubscribed Private Placement
1M ago
8K
RNXT
RenovoRx prices 10.6M shares at 93.8c in private placement
Premium
The Fly
RenovoRx prices 10.6M shares at 93.8c in private placement
1M ago
RNXT
RenovoRx advances RenovoCath adoption at U.S. cancer centers
PremiumThe Fly
RenovoRx advances RenovoCath adoption at U.S. cancer centers
2M ago
RNXT
RenovoRx announces acceptance of clinical data abstract at 2026 SIR
PremiumThe Fly
RenovoRx announces acceptance of clinical data abstract at 2026 SIR
2M ago
RNXT
RenovoRx establishes RenovoCath Medical Advisory Board
PremiumThe Fly
RenovoRx establishes RenovoCath Medical Advisory Board
3M ago
RNXT
RenovoRx Appoints Veteran Executive Mark Voll as CFO
PremiumCompany Announcements
RenovoRx Appoints Veteran Executive Mark Voll as CFO
3M ago
8K
RNXT
RenovoRx appoints Voll as Chief Financial Officer
PremiumThe FlyRenovoRx appoints Voll as Chief Financial Officer
3M ago
RNXT
RenovoRx announces new clinical data on TAMP therapy platform
Premium
The Fly
RenovoRx announces new clinical data on TAMP therapy platform
3M ago
RNXT
RenovoRx initiated with a Buy at JonesResearch
Premium
The Fly
RenovoRx initiated with a Buy at JonesResearch
3M ago
RNXT
RenovoRx expands RenovoCath commercial adoption to nine cancer centers
PremiumThe Fly
RenovoRx expands RenovoCath commercial adoption to nine cancer centers
3M ago
RNXT
RenovoRx to announce new clinical data from Phase III TIGeR-PaC trial
PremiumThe Fly
RenovoRx to announce new clinical data from Phase III TIGeR-PaC trial
4M ago
RNXT
RenovoRx Receives Nasdaq Notice for Bid Price Noncompliance
PremiumCompany Announcements
RenovoRx Receives Nasdaq Notice for Bid Price Noncompliance
4M ago
8K
RNXT
Strategic Expansion and Promising Clinical Results Justify Buy Rating for RenovoRx
PremiumRatings
Strategic Expansion and Promising Clinical Results Justify Buy Rating for RenovoRx
5M ago
RNXT
RenovoRx’s Innovative Cancer Treatment and Promising Phase 3 Study Drive Buy Rating
PremiumRatingsRenovoRx’s Innovative Cancer Treatment and Promising Phase 3 Study Drive Buy Rating
6M ago
RNXT
RenovoRx Earnings Call: Positive Momentum and Strategic Growth
Premium
Company Announcements
RenovoRx Earnings Call: Positive Momentum and Strategic Growth
6M ago
RNXT
RenovoRx Enters Capital on Demand Sales Agreement
Premium
Company Announcements
RenovoRx Enters Capital on Demand Sales Agreement
6M ago
8K
RNXT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >